Found: 86
Select item for more details and to access through your institution.
Brain histamine H<sub>1</sub> receptor occupancy after oral administration of desloratadine and loratadine.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 4, p. N.PAG, doi. 10.1002/prp2.499
- By:
- Publication type:
- Article
In vivo Detection of Amyloid Plaques in the Mouse Brain using the Near-Infrared Fluorescence Probe THK-265.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 23, n. 1, p. 37, doi. 10.3233/JAD-2010-100270
- By:
- Publication type:
- Article
Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line.
- Published in:
- Journal of Neurochemistry, 2014, v. 129, n. 4, p. 591, doi. 10.1111/jnc.12665
- By:
- Publication type:
- Article
Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brain.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0253-y
- By:
- Publication type:
- Article
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non Alzheimer's disease tauopathies.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 1, p. 1, doi. 10.1186/alzrt240
- By:
- Publication type:
- Article
Tau PET Imaging in Alzheimer's Disease.
- Published in:
- Current Neurology & Neuroscience Reports, 2014, v. 14, n. 11, p. 1, doi. 10.1007/s11910-014-0500-6
- By:
- Publication type:
- Article
Characterization of murine polyspecific monoamine transporters.
- Published in:
- FEBS Open Bio, 2017, v. 7, n. 2, p. 237, doi. 10.1002/2211-5463.12183
- By:
- Publication type:
- Article
The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein.
- Published in:
- Molecular Neurodegeneration, 2010, v. 5, p. 20, doi. 10.1186/1750-1326-5-20
- By:
- Publication type:
- Article
In vivo imaging of astrogliosis by PET.
- Published in:
- Folia Pharmacologica Japonica, 2023, v. 158, n. 1, p. 26, doi. 10.1254/fpj.22091
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0287047
- By:
- Publication type:
- Article
Development of [<sup>18</sup>F]SNFT‐1, a novel tau PET tracer with little off‐target binding: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042298
- By:
- Publication type:
- Article
Evaluation of the novel <sup>18</sup>F‐labeled PET tracer SMBT‐1 for imaging astrogliosis in healthy elderly controls and A+/T+/(N+) Alzheimer's disease patients: Neuroimaging: Novel imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039858
- By:
- Publication type:
- Article
P2‐384: DEVELOPMENT OF A NOVEL <sup>18</sup>F‐LABELED PET TRACER FOR IMAGING ASTROGLIOSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P750, doi. 10.1016/j.jalz.2019.06.2791
- By:
- Publication type:
- Article
IC‐P‐141: DEVELOPMENT OF A NOVEL <sup>18</sup>F‐LABELED PET TRACER FOR IMAGING ASTROGLIOSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4255
- By:
- Publication type:
- Article
IC‐P‐141: DEVELOPMENT OF A NOVEL <sup>18</sup>F‐LABELED PET TRACER FOR IMAGING ASTROGLIOSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4255
- By:
- Publication type:
- Article
P2‐379: POTENTIAL APPLICATION OF 18F‐THK5351 AND ITS DERIVATIVES FOR IMAGING ASTROGLIOSIS IN HUMAN BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P842, doi. 10.1016/j.jalz.2018.06.1070
- By:
- Publication type:
- Article
IC‐P‐223: TO TAU OR TO MAO‐B? MOST OF THE [F‐18]‐THK5351 SIGNAL IS BLOCKED BY SELEGILINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P181, doi. 10.1016/j.jalz.2018.06.2290
- By:
- Publication type:
- Article
IC‐P‐185: POTENTIAL APPLICATION OF 18F‐THK5351 AND ITS DERIVATIVES FOR IMAGING ASTROGLIOSIS IN HUMAN BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P155, doi. 10.1016/j.jalz.2018.06.2252
- By:
- Publication type:
- Article
LONGITUDINAL ASSESSMENT OF [18F]THK-5351 ACCUMULATION IN PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P137, doi. 10.1016/j.jalz.2017.06.2560
- By:
- Publication type:
- Article
SUCCESSFUL REDUCTION OF OFF-TARGET BINDING OF QUINOLINE DERIVATIVES AS TAU-SELECTIVE PET TRACERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P136, doi. 10.1016/j.jalz.2017.06.2557
- By:
- Publication type:
- Article
[F-18]THK5351 RETENTION IS ASSOCIATED WITH THE PROGRESSION OF BRAIN ATROPHY IN PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1094, doi. 10.1016/j.jalz.2016.06.2281
- By:
- Publication type:
- Article
IDENTIFICATION OF WAVELENGTH-DEPENDENT COMPOUNDS FOR IMAGING LEWY PATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1136, doi. 10.1016/j.jalz.2016.07.012
- By:
- Publication type:
- Article
[F-18]THK5351 RETENTION IS ASSOCIATED WITH THE PROGRESSION OF BRAIN ATROPHY IN PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P138, doi. 10.1016/j.jalz.2016.06.222
- By:
- Publication type:
- Article
Validation of the binding specificity of Tau PET tracer [18F]THK-5351 on postmortem human brain samples.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P271, doi. 10.1016/j.jalz.2015.06.190
- By:
- Publication type:
- Article
Validation of the binding specificity of Tau PET tracer [18F]THK-5351 on postmortem human brain samples.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P111, doi. 10.1016/j.jalz.2015.06.190
- By:
- Publication type:
- Article
Distribution of tau pathology in the patients with mild cognitive impairment and Alzheimer’s disease measured with [18F]THK-5351 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P791, doi. 10.1016/j.jalz.2015.06.189
- By:
- Publication type:
- Article
Distribution of tau pathology in patients with mild cognitive impairment and Alzheimer’s disease measured with [18F]THK-5351 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P111, doi. 10.1016/j.jalz.2015.06.189
- By:
- Publication type:
- Article
Tau positron emission tomography images with a novel tracer, 18F-THK5351, in a patient with progressive supranuclear palsy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P547, doi. 10.1016/j.jalz.2015.06.695
- By:
- Publication type:
- Article
Wavelength-dependent selective detection of tau pathology in Alzheimer's disease using a novel fluorescent probe THK-1188
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Novel 18F-labeled quinoline derivatives for in vivo detection of tau pathology in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Near-infrared fluorescence probe X50 for in vivo detection of amyloid plaques in the brain
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Preclinical Characterization of the Tau PET Tracer [ <sup>18</sup>F]SNFT-1: Comparison of Tau PET Tracers.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1495, doi. 10.2967/jnumed.123.265593
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer’s disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
First-in-human evaluation of 18F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer’s disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer’s disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
First-in-human evaluation of 18F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
<sup>18F</sup>-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244400
- By:
- Publication type:
- Article
<sup>18</sup>F-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244400
- By:
- Publication type:
- Article
<sup>18</sup>F-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244400
- By:
- Publication type:
- Article
<sup>18</sup>F-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244400
- By:
- Publication type:
- Article